Loading data for OGEN — first visit, this takes a few seconds.
Oragenics, Inc. (OGEN)
NYSE American: OGEN
· 即時價格 · USD
0.51
+0.01 (2.00%)
收盤價： Sep 04, 2026, 3:59 PM
0.54
+4.90%
盤後: 6:42 PM
股價、關鍵數字和最新消息，都在這一頁。
Oragenics, Inc.（OGEN）股價、分析與資料
2.31% (1D)
| 買價 | 0.5 |
| 市值 | 2.3M |
| 營收 (ttm) | n/a |
| 淨利（ttm） | -10.1M |
| 1.25 | |
| 0.98 | |
| 0.52 | |
| -0.05 | |
| P/B (ttm) | 0.63 |
| P/S (ttm) | 0.00 |
| 財報日期 | n/a |
| 賣價 | 0.54 |
| 成交量 | 8,312 |
| 20 日平均成交量 | 33,392 |
| 開盤價 | 0.50 |
| 前收盤價 | 0.50 |
| 當日區間 | 0.50 - 0.52 |
| 52 週範圍 | 0.48 - 1.45 |
| 分析師 | n/a |
| 目標價 | n/a |
| 股利 | n/a |
| 除息日 | n/a |
關於 OGEN
Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical therapies neurological conditions and infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid, which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene ampli...
完整的公司簡介財報驚奇
Oragenics 已於 May 12, 2023 公布季度財報：
- 營收為 n/a 低於預期 $0, 年增 NaN% 成長.
- 每股盈餘為 -42.3 超出預期 47.71, 年增 53.01% 成長.
